These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 8160053)
21. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642 [TBL] [Abstract][Full Text] [Related]
22. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Quiambao BP; Dimaano EM; Ambas C; Davis R; Banzhoff A; Malerczyk C Vaccine; 2005 Feb; 23(14):1709-14. PubMed ID: 15705476 [TBL] [Abstract][Full Text] [Related]
23. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans. Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504 [TBL] [Abstract][Full Text] [Related]
24. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals]. Baysal B; Tosun S; Ozdemir M; Doğan M Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389 [TBL] [Abstract][Full Text] [Related]
25. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers". Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Matha IS; Salunke SR Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086 [TBL] [Abstract][Full Text] [Related]
27. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vodopija I; Sureau P; Smerdel S; Lafon M; Baklaić Z; Ljubicić M; Svjetlicić M Vaccine; 1988 Jun; 6(3):283-6. PubMed ID: 3420976 [TBL] [Abstract][Full Text] [Related]
28. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Lin FT; Chen SB; Wang YZ; Sun CZ; Zeng FZ; Wang GF Rev Infect Dis; 1988; 10 Suppl 4():S766-70. PubMed ID: 3206088 [TBL] [Abstract][Full Text] [Related]
29. Presumptive abortive human rabies - Texas, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Feb; 59(7):185-90. PubMed ID: 20186117 [TBL] [Abstract][Full Text] [Related]
31. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
32. Seroconversion following incomplete human rabies postexposure prophylaxis. Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309 [TBL] [Abstract][Full Text] [Related]
33. [Immunogenicity, efficacy and reactogenicity of a human diploid cell strain (HDCS) rabies vaccine in man; recommendations for pre- and post-exposure application (vaccination scheme) (author's transl)]. Kuwert EK; Marcus I; Höher PG; Werner J; Iwand A; Helm EB Med Klin; 1977 May; 72(18):797-805. PubMed ID: 865381 [TBL] [Abstract][Full Text] [Related]